DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

DIA Global Center

2019 年 10 月 28 日 8:15 上午 - 2019 年 10 月 29 日 4:30 下午

21 Dupont Circle NW, Suite 300, Washington, DC 20036

Regulatory Affairs for Combination Products

Learn about FDA's approach to regulation of combination products, the processes to streamline development of single entity, and aligning requirements between drugs and devices.

Session 10: Post-Approval Changes

Session Chair(s)

Carol H. Danielson, DrPH, MS, RAC

Carol H. Danielson, DrPH, MS, RAC

President

Regulatory Advantage, LLC, United States

  • Device and drug changes made to products approved via PMA
  • Device and drug changes made to products approved via NDA

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。